Molecular analysis of clear cell renal cell carcinoma progression in the context of the search for predictive factors prior to treatment

2013/09/D/NZ5/00249

Keywords

Descriptors

  • NZ5_3: Patogeneza chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Katarzyna Miękus

Number of co-investigators in the project: 6

Call

SONATA 5 – announced on 2013-03-15

Amount awarded
754 120 PLN
Project start date
2014-03-28
Project end date
2018-03-27
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. aparatura do metody western blot. Cost: 10 000 PLN
  2. drukarka. Cost: 500 PLN
  3. homogenizator tkanek. Cost: 10 000 PLN
  4. komputer przenośny. Cost: 5 000 PLN
  5. komputer stacjonarny. Cost: 2 861 PLN
  6. wirówka. Cost: 25 000 PLN

Information in the final report

Publication in academic press/journals (3)

  1. RNAza MCPIP1 jako istotny regulator wewnątrzkomórkowej puli RNA

    Authors:
    Pydyn N, Miękus K, Kotlinowski J
    Academic press:
    Postępy Higieny i Medycyny Doświadczalnej (year: 2018, volume: 72, pages: 0,0479166666666667), Publisher: Czasopismo Instytutu Immunologii i Terapii Doświadczalnej Polskiej Akademii Nauk im. Ludwika Hirszfelda
    Status:
    Published
    DOI:
    10.5604/01.3001.0011.8255 – link to the publication
  2. MCPIP1 downregulation in clear cell renal cell carcinoma promotes vascularization and metastatic progression

    Authors:
    Marona P, Górka J, Mazurek Z, Wilk W, Rys J, Majka M, Jura J, Miekus K
    Academic press:
    Cancer Research (year: 2017, volume: 77(18), pages: 4905-4920), Publisher: AACR journals
    Status:
    Published
    DOI:
    10.1158/0008-5472.CAN-16-3190 – link to the publication
  3. The Met tyrosine kinase receptor as a therapeutic target and a potential cancer stem cell factor responsible for therapy resistance

    Authors:
    Miekus K
    Academic press:
    Oncology Reports (year: 2017, volume: 37 (2), pages: 647-656), Publisher: Spandisos Publications
    Status:
    Published
    DOI:
    10.3892/or.2016.5297 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski